PHIBRO ANIMAL HEALTH CORP-A
PAHCNASDAQTrading Snapshot
- Day Range
- $35.61 β $36.40
- 52-Week Range
- $28.25 β $60.08
- Volume
- $2.43B
- Avg Volume
- $2.08B
- Shares Outstanding
- 40.6M
- Next Earnings
- Nov 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.52B
- Last Q Revenue
- $397M
- P/E Ratio
- 14.5
- P/S Ratio
- 1.0x
- EPS (TTM)
- $2.43
- Dividend Yield
- 1.34%
- Dilution (1yr)
- +0.1%
Why Investors Own PAHC
- βHigh-growth profile β revenue up +7.7% YoY with expanding US Equity exposure.
- βHealthy economics β 40% gross margin and 5% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
PHIBRO ANIMAL HEALTH CORP-A
PAHCAbout PHIBRO ANIMAL HEALTH CORP-A
Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Best Momentum Stocks to Buy for September 21st
SEI, SDRL and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 21st, 2026.

PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value o

Phibro Animal Health Corporation $PAHC Shares Acquired by Engineers Gate Manager LP
Engineers Gate Manager LP boosted its position in Phibro Animal Health Corporation (NASDAQ: PAHC) by 112.8% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchang

4 Stocks With Strong Interest Coverage to Buy as Yields Rise
DiamondRock Hospitality, Vertiv, Mueller Water Products and Phibro Animal Health stand out for strong interest coverage as Treasury yields rise.

Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. President & Chief Executive Officer, Daniel B